Ursodeoxycholic acid in primary sclerosing cholangitis: If withdrawal is bad, then administration is good (right?)
Potential conflict of interest: Nothing to report.
See Article on Page 931
This work was funded by T32DK007198 (training grant support for J.H.T.) and UL1TR000135 (to the Mayo Clinic Center for Clinical and Translational Science).